Eradication of Helicobacter pylori in functional dyspepsia. Study had several weaknesses.
作者信息
McColl K E, Gillen D, Dickson A S
出版信息
BMJ. 1999 Aug 14;319(7207):451; author reply 451-2. doi: 10.1136/bmj.319.7207.451.
Abstract
摘要
相似文献
1
Eradication of Helicobacter pylori in functional dyspepsia. Study had several weaknesses.根除幽门螺杆菌治疗功能性消化不良。该研究存在若干不足之处。
BMJ. 1999 Aug 14;319(7207):451; author reply 451-2. doi: 10.1136/bmj.319.7207.451.
2
Will eradication of Helicobacter pylori improve symptoms of non-ulcer dyspepsia? This meta-analysis is potentially misleading.根除幽门螺杆菌会改善非溃疡性消化不良的症状吗？这项荟萃分析可能会产生误导。
BMJ. 2000 Apr 29;320(7243):1208-9; author reply 1210.
3
4
5
Will eradication of Helicobacter pylori improve symptoms of non-ulcer dyspepsia? Meta-analysis included unreliable studies.根除幽门螺杆菌会改善非溃疡性消化不良的症状吗？荟萃分析纳入了不可靠的研究。
BMJ. 2000 Apr 29;320(7243):1209; author reply 1210.
6
Helicobacter pylori eradication for nonulcer dyspepsia is of limited value.根除幽门螺杆菌对非溃疡性消化不良的价值有限。
J Fam Pract. 2000 Jan;49(1):10, 77.
7
Who benefits from Helicobacter pylori eradication?谁能从根除幽门螺杆菌中获益？
BMJ. 2006 Jan 28;332(7535):187-8. doi: 10.1136/bmj.332.7535.187.
8
9
Cost effectiveness of screening for and eradication of Helicobacter pylori in young patients with dyspepsia. Analysis is easier with spreadsheets than decision trees.年轻消化不良患者幽门螺杆菌筛查与根除的成本效益。使用电子表格进行分析比使用决策树更容易。
BMJ. 1996 Sep 7;313(7057):622; author reply 623. doi: 10.1136/bmj.313.7057.622.
10
Cost effectiveness of screening for and eradication of Helicobacter pylori in young patients with dyspepsia. Comparison groups were not clear in study.年轻消化不良患者幽门螺杆菌筛查与根除的成本效益。研究中对照组不明确。
BMJ. 1996 Sep 7;313(7057):623. doi: 10.1136/bmj.313.7057.623.
引用本文的文献
1
Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia. Dyspepsia Review Group.幽门螺杆菌根除治疗非溃疡性消化不良的系统评价与经济学评估。消化不良综述小组。
BMJ. 2000 Sep 16;321(7262):659-64. doi: 10.1136/bmj.321.7262.659.
本文引用的文献
1
Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up. The Optimal Regimen Cures Helicobacter Induced Dyspepsia (ORCHID) Study Group.根除幽门螺杆菌治疗功能性消化不良：一项为期12个月随访的随机双盲安慰剂对照试验。最佳方案治愈幽门螺杆菌所致消化不良（ORCHID）研究组。
BMJ. 1999 Mar 27;318(7187):833-7. doi: 10.1136/bmj.318.7187.833.
2
Lack of effect of treating Helicobacter pylori infection in patients with nonulcer dyspepsia. Omeprazole plus Clarithromycin and Amoxicillin Effect One Year after Treatment (OCAY) Study Group.幽门螺杆菌感染治疗对非溃疡性消化不良患者无效。奥美拉唑联合克拉霉素和阿莫西林治疗一年后效果（OCAY）研究组。
N Engl J Med. 1998 Dec 24;339(26):1875-81. doi: 10.1056/NEJM199812243392602.
3
Symptomatic benefit from eradicating Helicobacter pylori infection in patients with nonulcer dyspepsia.根除幽门螺杆菌感染对非溃疡性消化不良患者的症状改善作用。
N Engl J Med. 1998 Dec 24;339(26):1869-74. doi: 10.1056/NEJM199812243392601.
4
Efficacy of omeprazole in functional dyspepsia: double-blind, randomized, placebo-controlled trials (the Bond and Opera studies).奥美拉唑治疗功能性消化不良的疗效：双盲、随机、安慰剂对照试验（邦德和歌剧研究）
Aliment Pharmacol Ther. 1998 Nov;12(11):1055-65. doi: 10.1046/j.1365-2036.1998.00410.x.
5
Efficacy and safety of the peripheral kappa agonist fedotozine versus placebo in the treatment of functional dyspepsia.外周κ激动剂非多托嗪与安慰剂治疗功能性消化不良的疗效及安全性比较
Gut. 1997 Nov;41(5):664-8. doi: 10.1136/gut.41.5.664.
6
The Helicobacter pylori breath test: a surrogate marker for peptic ulcer disease in dyspeptic patients.幽门螺杆菌呼气试验：消化不良患者消化性溃疡病的替代标志物。
Gut. 1997 Mar;40(3):302-6. doi: 10.1136/gut.40.3.302.
Zotero 插件